{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:04:47Z","timestamp":1778814287413,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.idnow.2025.105054","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T17:03:56Z","timestamp":1741280636000},"page":"105054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The neutrophil-to-lymphocyte ratio in bronchoalveolar lavage fluid could help to personalize corticosteroid therapy in severe COVID-19 pneumonia"],"prefix":"10.1016","volume":"55","author":[{"given":"Nausicaa","family":"Beaudequin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Glemain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Fajac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Fartoukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Voiriot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2025.105054_b0005","unstructured":"World Health Organization [Internet]. 2023. Therapeutics and COVID-19: living guideline, 10 November 2023 [cited November 27, 2024]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2023.2."},{"key":"10.1016\/j.idnow.2025.105054_b0010","doi-asserted-by":"crossref","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330. doi: 10.1001\/jama.2020.17023.","DOI":"10.1001\/jama.2020.17023"},{"issue":"2","key":"10.1016\/j.idnow.2025.105054_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.idnow.2025.105054_b0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.idnow.2025.105054_b0025","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/CCM.0000000000005930","article-title":"High-dose steroids for nonresolving acute respiratory distress syndrome in critically Ill COVID-19 patients treated with dexamethasone: a multicenter Cohort Study","volume":"51","author":"Lopinto","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.idnow.2025.105054_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243964","article-title":"High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response","volume":"16","author":"L\u00f3pez Z\u00fa\u00f1iga","year":"2021","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.idnow.2025.105054_b0035","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial","volume":"326","author":"Munch","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idnow.2025.105054_b0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00134-021-06573-1","article-title":"Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial","volume":"48","author":"Granholm","year":"2022","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.idnow.2025.105054_b0045","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamainternmed.2022.2168","article-title":"High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS randomized clinical trial","volume":"182","author":"Bouadma","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.idnow.2025.105054_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.idnow.2025.105054_b0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.idnow.2025.105054_b0060","doi-asserted-by":"crossref","first-page":"9502","DOI":"10.1038\/s41598-022-13179-0","article-title":"Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients","volume":"12","author":"Voiriot","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.idnow.2025.105054_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1183\/09031936.00069509","article-title":"Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?","volume":"38","author":"Meyer","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.idnow.2025.105054_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106534","article-title":"Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease","volume":"186","author":"Kono","year":"2021","journal-title":"Respir Med"},{"issue":"9","key":"10.1016\/j.idnow.2025.105054_b0075","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/thorax-2023-219989","article-title":"Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality","volume":"78","author":"de Brabander","year":"2023","journal-title":"Thorax"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T23:50:24Z","timestamp":1745884224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991925000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666991925000338"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105054","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neutrophil-to-lymphocyte ratio in bronchoalveolar lavage fluid could help to personalize corticosteroid therapy in severe COVID-19 pneumonia","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105054"}}